UPSA in the news
Healthcare products manufacturing company
Tamtam found 20 recent articles about UPSA.
- Prix de l’économie Néo Aquitains : « En tant que Présidente du jury j’ai souvent été bluffée », assure Isabelle Van Rycke, PDG d’Upsa
Isabelle Van Rycke, CEO of Upsa, presided over the 2026 Neo Aquitaine Economy Awards jury, sharing insights on the experience and Upsa's current activities.
- Senior – UPSA mobilisée contre la douleur
UPSA organizes a meeting to discuss and reinvent pain management for the elderly, addressing evolving needs and challenging current practices.
- Paracétamol français : le bras de fer sur les prix menace la relocalisation industrielle
A pricing dispute over a seven-cent increase for paracetamol threatens the French government's strategic project to re-shore its production.
- Ce laboratoire pharmaceutique veut que l'Etat achète plus cher ses médicaments "Made in France" au nom de la souveraineté
Upsa, a French pharmaceutical company, is advocating for the French government to increase its purchase price for domestically produced medications, citing sovereignty and production costs, while the government considers a price reduction.
- Atlas Metals Group Terminates SPA For Proposed Acquisition Of UPSA
Atlas Metals Group terminated its agreement to acquire UPSA.
- FEM By UPSA Highlights Growing Body of Research on
FEM By UPSA showcases robust scientific and clinical evidence for FEM Meno, a non-hormonal dietary supplement with Pure CyTonin® for managing menopause symptoms, particularly for women with a history of breast cancer.
- Upsa demande une augmentation du prix du paracétamol : « Nous demandons un partage des coûts entre tous les acteurs, dont l’État »
Upsa is requesting a paracetamol price increase as a moratorium ends and rising costs threaten to lower its selling price.
- Paracétamol : pourquoi son prix pourrait augmenter en pharmacie
UPSA and other French pharmaceutical manufacturers are requesting a price increase for domestically produced paracetamol, citing production costs and advocating for higher remuneration for mature medicines, as negotiations with the state continue.
- Pourquoi le prix du paracétamol risque d’augmenter dans les prochains jours dans votre pharmacie ?
Upsa and Med France are pushing for a price increase for domestically produced paracetamol like Dafalgan due to increased manufacturing costs and the end of a price freeze.
- Vers une hausse du prix du paracétamol en pharmacie ? Pourquoi ces laboratoires exigent de revoir les tarifs dans les prochaines semaines
Upsa and the Med France union are pushing for a price increase for paracetamol manufactured in France, currently frozen at 0.76 euros, to reflect production costs and support domestic manufacturing.
- Agen : Upsa mise sur le bien-être et poursuit ses investissements pour la souveraineté sanitaire
Upsa expands its product range to include wellness and food supplements while maintaining its presence in French pharmacies with iconic brands.
- Visitez les usines UPSA à Agen durant la Semaine de l'Industrie
UPSA will open its pharmaceutical production sites in Agen, France, for public visits during Industry Week in November 2026 to showcase its manufacturing, history, and local impact.
- Semaine de l’industrie : trois jours pour découvrir les coulisses de la fabrication des médicaments chez UPSA
UPSA is offering public tours of its pharmaceutical manufacturing facilities in Lot-et-Garonne from November 16-18, 2026, to showcase drug production and industry careers.
- FEM By UPSA Appoints U.S. Advisors to Advance Science-Backed, Non-Hormonal Menopause Support
FEM By UPSA appointed two U.S. advisors to advance its science-backed, non-hormonal menopause support products and strengthen healthcare professional education in the U.S. market.
- FEM By UPSA Appoints U.S. Advisors to Advance Science-Backed, Non-Hormonal Menopause Support
FEM By UPSA appointed two U.S. clinical and scientific advisors to advance its science-backed, non-hormonal menopause support in the U.S. market.
- FEM By UPSA Appoints U.S. Advisors to Advance Science-Backed, Non-Hormonal Menopause Support
FEM By UPSA appointed U.S. advisors to advance its science-backed, non-hormonal menopause support products through research and professional education.
- Industrie – UPSA ouvre les portes de ses sites agenais
UPSA is opening its pharmaceutical production sites in Agen to the public for tours during Industry Week.
- Semaine de l’industrie : trois jours pour découvrir les coulisses de la fabrication des médicaments chez UPSA
UPSA is opening its manufacturing sites to the public for tours during Industry Week to showcase drug production and careers.
- Santé — UPSA avec les professionnels de santé à Paris
UPSA hosted an event for healthcare professionals in Paris discussing the evolution and advancements in pain management.
- Semaine de l'Industrie : UPSA ouvre ses portes à Agen
UPSA will open its manufacturing sites in Agen and Le Passage, France, to the public from November 16-18, 2026, to showcase its pharmaceutical production and local economic impact, with free guided tours.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like UPSA?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies